VioQuest Pharmaceuticals, Inc.

Pharmaceutical company reports 45% increase in revenue for fiscal Q3 2005

Published in Law and Health Weekly, November 19th, 2005

VioQuest Pharmaceuticals, Inc., (VQPH) reported revenue of approximately $533,000 for the third quarter of 2005 compared to $367,000 for the third quarter of 2004, an increase of approximately $170,000, or 45% quarter-over-quarter.

For the 9 months ended September 30, 2005, VioQuest reported revenue of approximately $2.6 million, compared to revenue of $1.1 million for the 9 months ended September 30, 2004, or an increase of approximately 136%. During the third quarter, the company's subsidiary, Chiral Quest signed a license agreement with Merck & Co. to supply a variety of chiral catalysts and ligands.

As a pioneer in asymmetric synthesis, Chiral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2005-11-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry